{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:16Z","timestamp":1793313616095,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1871,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.jhep.2008.03.009","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T08:11:07Z","timestamp":1207037467000},"page":"1000-1007","source":"Crossref","is-referenced-by-count":495,"title":["Thrombocytopenia associated with chronic liver disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Nezam","family":"Afdhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McHutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Poordad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette","family":"Weksler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2008.03.009_bib1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2036.2006.02889.x","article-title":"Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options","volume":"23","author":"Giannini","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2008.03.009_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2007.01.015","article-title":"Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research","volume":"46","author":"Tripodi","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.03.009_bib3","doi-asserted-by":"crossref","first-page":"60D","DOI":"10.1155\/2000\/617428","article-title":"Thrombocytopenia in liver disease","volume":"14","author":"Peck-Radosavljevic","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.03.009_bib4","first-page":"198","article-title":"Platelet transfusion therapy for the cancer patient","volume":"17","author":"Heyman","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jhep.2008.03.009_bib5","first-page":"381","article-title":"Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults","volume":"2","author":"George","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.jhep.2008.03.009_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.gastro.2005.11.010","article-title":"American Gastroenterological Association technical review on the management of hepatitis C","volume":"130","author":"Dienstag","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.03.009_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00004836-200201000-00016","article-title":"Prediction of esophageal varices in patients with cirrhosis","volume":"34","author":"Madhotra","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2008.03.009_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1590-8658(03)00219-6","article-title":"Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis","volume":"35","author":"Thomopoulos","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2008.03.009_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","article-title":"Pooling of platelets in the spleen: role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia","volume":"45","author":"Aster","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2008.03.009_bib10","series-title":"The spleen: structure, function and clinical significance","first-page":"209","article-title":"The syndromes of splenic dysfunction: a clinical overview","author":"Toghill","year":"1990"},{"key":"10.1016\/j.jhep.2008.03.009_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2141.2000.02132.x","article-title":"HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy","volume":"110","author":"Garcia-Suarez","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2008.03.009_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1086\/423384","article-title":"Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection","volume":"39","author":"Wang","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2008.03.009_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1530-0277.1989.tb00408.x","article-title":"Hematological complications of alcoholism","volume":"13","author":"Ballard","year":"1989","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2008.03.009_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ajh.2830500305","article-title":"Platelet autoantibodies in patients with chronic liver disease","volume":"50","author":"Pereira","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhep.2008.03.009_bib15","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.03.009_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.idc.2006.01.007","article-title":"Antiviral therapy for treatment naive patients with hepatitis C virus","volume":"20","author":"Oh","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jhep.2008.03.009_bib17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2008.03.009_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/gast.2002.35950","article-title":"Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C","volume":"123","author":"McHutchison","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.03.009_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.03.009_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0272-5231(03)00100-X","article-title":"Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients","volume":"24","author":"Drews","year":"2003","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0889-8588(18)30129-1","article-title":"Transfusion therapy in acquired coagulopathies","volume":"8","author":"Humphries","year":"1994","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jhep.2008.03.009_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199809103391107","article-title":"Thrombopoietin","volume":"339","author":"Kaushansky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib25","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoietin: basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2008.03.009_bib26","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/hep.510280535","article-title":"Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C","volume":"28","author":"Peck-Radosavljevic","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.03.009_bib27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1572-0241.2005.41543.x","article-title":"The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis","volume":"100","author":"Rios","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.03.009_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/lv 2000.6138","article-title":"Intracerebral hemorrhage after liver transplantation","volume":"6","author":"Wang","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2008.03.009_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4065\/70.5.443","article-title":"Intracerebral hemorrhage in liver transplant recipients","volume":"70","author":"Wijdicks","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2008.03.009_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0889-8553(05)70111-4","article-title":"Hematologic management of gastrointestinal bleeding","volume":"29","author":"Maltz","year":"2000","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhep.2008.03.009_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajem.2004.10.005","article-title":"Clinical predictors of bleeding esophageal varices in the ED","volume":"23","author":"Goh","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11894-004-0023-4","article-title":"Controversies in liver biopsy: who, where, when, how, why?","volume":"6","author":"Friedman","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhep.2008.03.009_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ajcp\/94.6.747","article-title":"Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities","volume":"94","author":"McVay","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jhep.2008.03.009_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00464-004-8722-3","article-title":"Cirrhosis is not a contraindication to laparoscopic surgery","volume":"19","author":"Cobb","year":"2005","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jhep.2008.03.009_bib35","first-page":"603","article-title":"Laparoscopic liver biopsy in patients with coagulopathy, portal hypertension, and ascites","volume":"61","author":"Inabnet","year":"1995","journal-title":"Am Surg"},{"key":"10.1016\/j.jhep.2008.03.009_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.RVI.0000058413.01661.b9","article-title":"Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia","volume":"14","author":"Wallace","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2008.03.009_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1537-2995.1991.31291142949.x","article-title":"Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities","volume":"31","author":"McVay","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.jhep.2008.03.009_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.20317","article-title":"Performance standards for therapeutic abdominal paracentesis","volume":"40","author":"Grabau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.03.009_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2005.02387.x","article-title":"Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease","volume":"21","author":"Pache","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2008.03.009_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.1989.7.6.798","article-title":"The safety of dental extractions in patients with hematologic malignancies","volume":"7","author":"Williford","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2008.03.009_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2008.03.009_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1423-0410.2000.tb00058.x","article-title":"Trigger for platelet transfusion","volume":"78","author":"Rebulla","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.jhep.2008.03.009_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00062752-199911000-00015","article-title":"Optimal dosing and triggers for prophylactic use of platelet transfusions","volume":"6","author":"Rinder","year":"1999","journal-title":"Curr Opin Hematol"},{"issue":"2 Suppl. 4","key":"10.1016\/j.jhep.2008.03.009_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0037-1963(00)90047-7","article-title":"Current issues with platelet transfusion in patients with cancer","volume":"37","author":"McCullough","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jhep.2008.03.009_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/blre.2001.0151","article-title":"Non-infectious complications of transfusion therapy","volume":"15","author":"Perrotta","year":"2001","journal-title":"Blood Rev"},{"key":"10.1016\/j.jhep.2008.03.009_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1665-2681(19)32033-2","article-title":"The use of TIPS in chronic liver disease","volume":"5","author":"Wong","year":"2006","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2008.03.009_bib47","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1023\/A:1026634215918","article-title":"Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?","volume":"43","author":"Jabbour","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2008.03.009_bib48","first-page":"361A","article-title":"Safety and efficacy of recombinant human IL-11 (oprelvekin) in combination with interferon\/ribavirin therapy in hepatitis C patients with thrombocytopenia. Annual Meeting of the American Society of Hematology; 2002; Philadelphia, PA","volume":"100","author":"Rustgi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2008.03.009_bib49","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/cncr.11447","article-title":"Rubenstein EB. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy","volume":"97","author":"Cantor","year":"2003","journal-title":"Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.jhep.2008.03.009_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1634\/theoncologist.6-suppl_5-15","article-title":"Targeted approaches for the treatment of thrombocytopenia","volume":"6","author":"Demetri","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.jhep.2008.03.009_bib51","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib52","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2006-11-057968","article-title":"Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2008.03.009_bib53","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.03.009_bib54","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2003.08.003","article-title":"Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia","volume":"21","author":"Vadhan-Raj","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2008.03.009_bib55","first-page":"137","article-title":"Thrombopoietic growth factors and cytokines","volume":"4","author":"Vadhan-Raj","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.jhep.2008.03.009_bib56","first-page":"3118","article-title":"Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer","volume":"89","author":"Basser","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2008.03.009_bib57","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(96)04471-6","article-title":"Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer","volume":"348","author":"Basser","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2008.03.009_bib58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood.V86.2.540.bloodjournal862540","article-title":"Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor","volume":"86","author":"Hunt","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2008.03.009_bib59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2003-10-3623","article-title":"Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities","volume":"104","author":"Inagaki","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2008.03.009_bib60","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827808002213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827808002213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T06:01:51Z","timestamp":1738130511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827808002213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0168827808002213"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2008.03.009","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}